Our results demonstrate that QDHXY suppresses inflammation by enhancing eNOS expression and inhibiting the expression of caveolin-1 and MyD88, which might facilitate its clinical applications in the management of ALI. The gene discussed is NOS3; the disease is acute respiratory distress syndrome.